Insider · CIK 0001683607

Bassler Bonnie L

Reports to the SEC for 4 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001683607

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	RPRXRoyalty Pharma plcA Award	Director	AAward	+642 sh	$58.41	+$37.5K	79,823
2026-06-30	RPRXRoyalty Pharma plcA Award	Director	AAward	+689 sh	$54.40	+$37.5K	79,181
2026-06-05	RPRXRoyalty Pharma plcA Award	Director	AAward	+4,545 sh	—	—	78,492
2026-03-31	RPRXRoyalty Pharma plcA Award	Director	AAward	+815 sh	$45.98	+$37.5K	73,947
2026-01-07	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$374.12	+$561K	3,203
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.1K sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−15 sh	$221.50	−$3,322.5	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,125 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,400 sh	—	—	0
2026-01-07	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	2,861
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,750 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,125 sh	—	—	0
2026-01-07	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,500 sh	$800.00	−$1.2M	1,703
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−875 sh	—	—	0
2026-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+155 sh	—	—	1,703
2026-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,962 sh	—	—	1,962
2025-12-31	RPRXRoyalty Pharma plcA Award	Director	AAward	+967 sh	$38.74	+$37.5K	73,132
2025-11-20	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−760 sh	$750.00	−$570K	1,548
2025-11-20	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−760 sh	—	—	756
2025-11-20	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+760 sh	$371.40	+$282K	2,308
2025-09-30	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,047 sh	$35.79	+$37.5K	72,165
2025-06-30	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,064 sh	$35.24	+$37.5K	71,118
2025-06-18	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.1K sh	—	—	11,100
2025-05-13	RPRXRoyalty Pharma plcA Award	Director	AAward	+7,614 sh	—	—	70,054
2025-03-31	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,141 sh	$32.87	+$37.5K	62,440
2025-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+166 sh	—	—	1,548
2025-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,958 sh	—	—	1,958
2024-12-31	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,503 sh	$24.94	+$37.5K	61,299
2024-12-17	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-09-30	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,342 sh	$27.92	+$37.5K	59,796
2024-08-15	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+756 sh	$371.40	+$281K	2,138
2024-08-15	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−756 sh	$1170.00	−$885K	1,382
2024-08-15	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−756 sh	—	—	1,516
2024-08-02	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+756 sh	$371.40	+$281K	2,138
2024-08-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−756 sh	—	—	2,272
2024-08-02	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−756 sh	$1115.00	−$843K	1,382
2024-07-18	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,125 sh	—	—	2,125
2024-06-28	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,399 sh	$26.80	+$37.5K	58,454
2024-06-24	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−756 sh	—	—	3,028
2024-06-24	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−756 sh	$1062.00	−$803K	1,382
2024-06-24	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+756 sh	$371.40	+$281K	2,138
2024-06-07	RPRXRoyalty Pharma plcA Award	Director	AAward	+9,293 sh	—	—	57,055
2024-06-05	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−827 sh	—	—	0
2024-06-05	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−827 sh	$1011.00	−$836K	1,382
2024-06-05	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+827 sh	$380.95	+$315K	2,209
2024-03-28	RPRXRoyalty Pharma plcA Award	Director	AAward	+1,240 sh	$30.23	+$37.5K	47,762
2024-02-26	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−854 sh	$979.25	−$836K	1,382
2024-02-26	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−854 sh	—	—	0
2024-02-26	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+854 sh	$391.92	+$335K	2,236

Recent filings

Accepted (ET)
Sep 304
Bassler Bonnie L0001683607-26-000016
SEC(opens sec.gov)
Jun 304
Bassler Bonnie L0001683607-26-000014
SEC(opens sec.gov)
Jun 84
Bassler Bonnie L0001683607-26-000012
SEC(opens sec.gov)
Mar 314
Bassler Bonnie L0001683607-26-000010
SEC(opens sec.gov)
Jan 84
Bassler Bonnie L0001683607-26-000008
SEC(opens sec.gov)
Jan 74
Bassler Bonnie L0001683607-26-000006
SEC(opens sec.gov)
Jan 64
Bassler Bonnie L0001683607-26-000004
SEC(opens sec.gov)
Jan 24
Bassler Bonnie L0001683607-26-000002
SEC(opens sec.gov)
Nov 244
Bassler Bonnie L0001683607-25-000006
SEC(opens sec.gov)

Companies

Address

C/O ROYALTY PHARMA PLC 110 E. 59TH STREET

NEW YORK, NY, 10022